Immuneering Corp SEC filings IMRX
Immuneering Corp has 322 filings in SEC EDGAR's recent list, going back to Oct 4, 2019. Its latest annual report, Form 10-K, was filed on Mar 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 15, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Other events
|
Jun 1, 2026 | Jun 1, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 15, 2026 | May 15, 2026 |
| DEFA14A | Additional proxy material | Apr 20, 2026 | — |
| DEF 14A | Proxy statement | Apr 20, 2026 | Apr 20, 2026 |
| 10-K | Annual report | Mar 6, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Other events
|
Jan 7, 2026 | Jan 7, 2026 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 424B5 | Prospectus supplement | Sep 25, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Sep 25, 2025 | Sep 24, 2025 |
| FWP | Free writing prospectus | Sep 25, 2025 | — |
| FWP | Free writing prospectus | Sep 24, 2025 | — |
| 424B5 | Prospectus supplement | Sep 24, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 24, 2025 | Sep 24, 2025 |
| D | Filing | Sep 9, 2025 | — |
| EFFECT | Filing | Sep 8, 2025 | — |
| 424B3 | Prospectus | Sep 8, 2025 | — |
| CORRESP | Letter to the SEC | Sep 4, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 4, 2025 | — |
| S-3 | Shelf registration | Sep 3, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Aug 25, 2025 | Aug 21, 2025 |
| EFFECT | Filing | Aug 20, 2025 | — |
| CORRESP | Letter to the SEC | Aug 18, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 18, 2025 | — |
| S-3 | Shelf registration | Aug 13, 2025 | — |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 424B5 | Prospectus supplement | Jun 23, 2025 | — |
| 8-K |
Current report
Other events
|
Jun 17, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2025 | Jun 13, 2025 |
| 10-Q | Quarterly report | May 5, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 5, 2025 | May 5, 2025 |
| S-8 | Employee stock plan registration | May 5, 2025 | — |
| DEFA14A | Additional proxy material | Apr 21, 2025 | — |
| DEF 14A | Proxy statement | Apr 21, 2025 | Apr 21, 2025 |
| 424B5 | Prospectus supplement | Mar 20, 2025 | — |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2025 | Mar 20, 2025 |
| 8-K |
Current report
Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Other events
|
Jan 7, 2025 | Jan 7, 2025 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Oct 2, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Other events
|
Sep 12, 2024 | Sep 12, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Officer or director change
|
May 23, 2024 | May 21, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| DEFA14A | Additional proxy material | Apr 23, 2024 | — |
| DEF 14A | Proxy statement | Apr 23, 2024 | Apr 23, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 14, 2024 | Mar 11, 2024 |
| 10-K | Annual report | Mar 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2024 | Mar 1, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 2, 2024 | Feb 1, 2024 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2023 | Jun 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 14, 2023 | Jun 13, 2023 |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 8-K | Current report | May 4, 2023 | May 4, 2023 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| DEF 14A | Proxy statement | May 1, 2023 | May 1, 2023 |
| 8-K |
Current report
Material agreement
|
Apr 19, 2023 | Apr 18, 2023 |
| 424B5 | Prospectus supplement | Apr 19, 2023 | — |
| 424B5 | Prospectus supplement | Apr 18, 2023 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Apr 18, 2023 | Apr 18, 2023 |
| 10-K | Annual report | Mar 6, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 6, 2023 | Mar 6, 2023 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K/A |
Amended current report
Officer or director change
|
Sep 19, 2022 | Jan 14, 2022 |
| EFFECT | Filing | Aug 19, 2022 | — |
| CORRESP | Letter to the SEC | Aug 17, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 17, 2022 | — |
| S-3 | Shelf registration | Aug 10, 2022 | — |
| 10-Q | Quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 25, 2022 | Jul 20, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2022 | Jun 21, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| DEFA14A | Additional proxy material | May 2, 2022 | — |
| DEF 14A | Proxy statement | May 2, 2022 | Jun 21, 2022 |
| 10-K | Annual report | Mar 10, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 18, 2022 | Jan 14, 2022 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Dec 22, 2021 | Dec 22, 2021 |
| 10-Q | Quarterly report | Nov 9, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 10-Q | Quarterly report | Sep 9, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Sep 9, 2021 | Sep 9, 2021 |
| S-8 | Employee stock plan registration | Aug 3, 2021 | — |
| 424B4 | Prospectus | Jul 30, 2021 | — |
| EFFECT | Filing | Jul 29, 2021 | — |
| S-1MEF | Filing | Jul 29, 2021 | — |
| CORRESP | Letter to the SEC | Jul 28, 2021 | — |
| S-1/A | Amended registration statement | Jul 28, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 27, 2021 | — |
| CERT | Filing | Jul 27, 2021 | — |
| CORRESP | Letter to the SEC | Jul 27, 2021 | — |
| CORRESP | Letter to the SEC | Jul 27, 2021 | — |
| 8-A12B | Filing | Jul 27, 2021 | — |
| S-1/A | Amended registration statement | Jul 26, 2021 | — |
| CORRESP | Letter to the SEC | Jul 14, 2021 | — |
| CORRESP | Letter to the SEC | Jul 9, 2021 | — |
| S-1 | Registration statement | Jul 9, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 1, 2021 | — |
| DRSLTR | Filing | Jun 21, 2021 | — |
| DRS/A | Filing | Jun 21, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2021 | — |
| DRS | Filing | May 13, 2021 | — |
| D | Filing | Jan 5, 2021 | — |
| D/A | Filing | Jan 27, 2020 | — |
| D | Filing | Oct 4, 2019 | — |
Showing 126 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IMRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1790340
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.